Aberration of Nrf2‑Bach1 pathway in colorectal carcinoma; role in carcinogenesis and tumor progression
- 22 November 2018
- journal article
- research article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 38, 138-144
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathyNephrology Dialysis Transplantation, 2013
- Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancerJournal of Biomedical Research, 2013
- Expression of UDP-glucuronosyltransferase 1A, nuclear factor erythroid-E2-related factor 2 and Kelch-like ECH-associated protein 1 in colonic mucosa, adenoma and adenocarcinoma tissueOncology Letters, 2012
- Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registryWorld Journal of Gastroenterology, 2012
- Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancerThe EMBO Journal, 2011
- RegNetB: Predicting Relevant Regulator-Gene Relationships in Localized Prostate Tumor SamplesBMC Bioinformatics, 2011
- Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic FeaturesClinical Cancer Research, 2010
- Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysemaThorax, 2008
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2Carcinogenesis, 2008
- Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder CarcinogenesisCancer Research, 2004